Literature DB >> 20363601

In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems.

Doron Yariv1, Rivka Efrat, Dima Libster, Abraham Aserin, Nissim Garti.   

Abstract

In this paper we examined feasible correlations between the structure of different lyotropic mesophases and transdermal administration of three diclofenac derivatives with varying degrees of kosmotropic or chaotropic properties, solubilized within the mesophases. It was found that the most chaotropic derivative of diclofenac diethyl amine (DEA-DFC) interacted with the polar heads of glycerol monooleate (GMO), thus expanding the water-lipid interface of the lamellar and cubic mesophases. This effect was detected by an increase in the lattice parameter of both mesophases, enhanced elastic properties, and increased solid-like response of the systems in the presence of DEA. Potassium diclofenac (K-DFC), a less chaotropic salt, had less pronounced effect on the structural features of the mesophases. Kosmotropic Na+ salt (Na-DFC) had only minor influence on both lamellar and cubic structures. The locus of solubilization of the molecules with the host mesophases was correlated with their delivery. It was suggested that transdermal delivery of kosmotropic Na-DFC was accelerated by the aqueous phase and less constrained by the interaction with monoglyceride. On the other hand, the chaotropic cations (K+ and DEA+), presumably entrapped in the water-lipid interface, interacted with monoglyceride headgroups, which is likely to be the key cause for their sustained administration. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363601     DOI: 10.1016/j.colsurfb.2010.02.029

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  9 in total

1.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

2.  Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.

Authors:  Thiagarajan Madheswaran; Rengarajan Baskaran; Raj Kumar Thapa; Jeong Yeon Rhyu; Hye Yoon Choi; Jong Oh Kim; Chul Soon Yong; Bong Kyu Yoo
Journal:  AAPS PharmSciTech       Date:  2012-12-04       Impact factor: 3.246

3.  Mapping ion-induced mesophasic transformation in lyotropic in situ gelling system and its correlation with pharmaceutical performance.

Authors:  Sharvil S Patil; Edakkal Venugopal; Suresh Bhat; Kakasaheb R Mahadik; Anant R Paradkar
Journal:  Pharm Res       Date:  2013-04-18       Impact factor: 4.200

Review 4.  Factors affecting the structure of lyotropic liquid crystals and the correlation between structure and drug diffusion.

Authors:  Yiming Huang; Shuangying Gui
Journal:  RSC Adv       Date:  2018-02-13       Impact factor: 4.036

5.  Formulation study of topically applied lotion: in vitro and in vivo evaluation.

Authors:  Syed Nisar Hussain Shah; Talib Hussain; Ikram Ullah Khan; Sajid Asghar; Yasser Shahzad
Journal:  Bioimpacts       Date:  2013-01-26

Review 6.  Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal.

Authors:  Juliana F de Souza; Katiusca da S Pontes; Thais F R Alves; Venâncio A Amaral; Márcia de A Rebelo; Moema A Hausen; Marco V Chaud
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

7.  Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes.

Authors:  Saeed Ghanbarzadeh; Sanam Arami
Journal:  Biomed Res Int       Date:  2013-07-14       Impact factor: 3.411

Review 8.  Cubic and hexagonal liquid crystals as drug delivery systems.

Authors:  Yulin Chen; Ping Ma; Shuangying Gui
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

9.  Microsponges based novel drug delivery system for augmented arthritis therapy.

Authors:  Riyaz Ali M Osmani; Nagesh H Aloorkar; Dipti J Ingale; Parthasarathi K Kulkarni; Umme Hani; Rohit R Bhosale; Dandasi Jayachandra Dev
Journal:  Saudi Pharm J       Date:  2015-03-07       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.